Inventor · disambiguated record
Laxmikant A. Gharat
Also filed as: GHARAT LAXMIKANT A · GHARAT LAXMIKANT ATMARAM
24 granted patents·10 pending applications·69 citations·filing 2003–2021
94Inventor score
Files withGLENMARK PHARMACEUTICALS SA25GHARAT LAXMIKANT ATMARAM4GHARAT LAXMIKANT A1GLENMARK PHARMACEUTICALS LTD1GLENMARK SPECIALTY SA1
Top patents by PatentIndex Score
34 records- 0186US9096545B2Triazolone compounds as mPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Aug 4, 2015·7 cites·36 claims
- 0285US9439890B2Triazolone compounds as mPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2015·Granted Sep 13, 2016·4 cites·21 claims
- 0384US7842703B2Substituted benzofused derivatives and their use as vanilloid receptor ligandsGLENMARK PHARMACEUTICALS SA·Filed 2006·Granted Nov 30, 2010·7 cites·40 claims
- 0482US10821100B2Triazolone compounds as mPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2019·Granted Nov 3, 2020·1 cites·8 claims
- 0581US7238725B2Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing themGLENMARK PHARMACEUTICALS LTD·Filed 2003·Granted Jul 3, 2007·21 cites·45 claims
- 0680US9949955B2Triazolone compounds as mPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted Apr 24, 2018·2 cites·12 claims
- 0779US7943634B2Substituted benzo[4,5]furo[3,2-c]pyridine derivatives as PDE 4 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2005·Granted May 17, 2011·3 cites·15 claims
- 0878US7223789B2Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing themGLENMARK PHARMACEUTICALS SA·Filed 2004·Granted May 29, 2007·13 cites·77 claims
- 0977US10391083B2Triazolone compounds as MPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Granted Aug 27, 2019·1 cites·14 claims
- 1077US7393846B2Heterocyclic compounds useful for the treatment of inflammatory and allergic disordersGLENMARK PHARMACEUTICALS SA·Filed 2006·Granted Jul 1, 2008·3 cites·88 claims
- 1177US7384962B2Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing themGLENMARK PHARMACEUTICALS SA·Filed 2006·Granted Jun 10, 2008·3 cites·25 claims
- 1263US10336688B2Carbocyclic compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Granted Jul 2, 2019·0 cites·10 claims
- 1362US10988467B2Compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2019·Granted Apr 27, 2021·0 cites·9 claims
- 1462US8519149B2Tricyclic compounds as mPGES-1 inhibitorsGHARAT LAXMIKANT A·Filed 2011·Granted Aug 27, 2013·2 cites·33 claims
- 1561US8129401B2Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing themGHARAT LAXMIKANT ATMARAM·Filed 2011·Granted Mar 6, 2012·1 cites·21 claims
- 1660US2009182143A1Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing themGLENMARK PHARMACEUTICALS SA·Filed 2008·Application pending·0 cites
- 1759US10457649B2Polymorphs of a mPGES-1 inhibiting triazolone compoundGLENMARK PHARMACEUTICALS SA·Filed 2018·Granted Oct 29, 2019·0 cites·8 claims
- 1858US8487121B2Chromane derivatives as TRPV3 modulatorsLINGAM V S PRASADARAO·Filed 2008·Granted Jul 16, 2013·1 cites·47 claims
- 1956US2009281146A1Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamideGLENMARK PHARMACEUTICALS SA·Filed 2009·Application pending·0 cites
- 2054US10112914B2Polymorphs of a mPGES-1 inhibiting triazolone compoundGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted Oct 30, 2018·0 cites·10 claims
- 2153US10344024B2Compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Granted Jul 9, 2019·0 cites·9 claims
- 2252US7563900B2Process for the preparation N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methane sulfonamido-dibenzo[b,d]furan-1-carboxamideGLENMARK PHARMACEUTICALS SA·Filed 2005·Granted Jul 21, 2009·0 cites·33 claims
- 2351US2008146810A1Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing themGLENMARK PHARMACEUTICALS SA·Filed 2007·Application pending·0 cites
- 2450US2012277259A1Substituted benzofused derivatives and their use as vanilloid receptor ligandsGHARAT LAXMIKANT ATMARAM·Filed 2012·Application pending·0 cites
- 2550US2011021549A1Substituted benzofused derivatives and their use as vanilloid receptor ligandsGLENMARK PHARMACEUTICALS SA·Filed 2010·Application pending·0 cites
- 2649US9975887B2Compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted May 22, 2018·0 cites·27 claims
- 2748US2023312486A1Polymorphic forms of a ror inhibiting compound and processes for its preparationGLENMARK SPECIALTY SA·Filed 2021·Application pending·0 cites
- 2847US2012041011A1Substituted benzofused derivatives and their use as vanilloid receptor ligandsGHARAT LAXMIKANT ATMARAM·Filed 2011·Application pending·0 cites
- 2946US2011184027A1Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identificationGLENMARK PHARMACEUTICALS SA·Filed 2008·Application pending·0 cites
- 3045US9006257B2Bicyclic compounds as mPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Apr 14, 2015·0 cites·42 claims
- 3143US10189775B2Carbocyclic compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted Jan 29, 2019·0 cites·15 claims
- 3241US2020247800A1Substituted bicyclic heterocyclic compounds as nadph oxidase inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 3339US8524905B2Processes for preparing 6-(difluoromethoxy)[1]benzofuro[3,2-c]pyridine-9-carbaldehyde, a novel intermediate for the synthesis of PDE IV inhibitorsGHARAT LAXMIKANT ATMARAM·Filed 2008·Granted Sep 3, 2013·0 cites·5 claims
- 3437US2023009626A1Indolinone compounds for use as map4k1 inhibitorsICHNOS SCIENCES S A·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →